Medical Properties Trust, Inc. (NYSE:MPW) declared a quarterly dividend on Thursday, August 15th, Zacks reports. Shareholders of record on Thursday, September 12th will be paid a dividend of 0.26 per share by the real estate investment trust on Thursday, October 10th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 5.48%. The ex-dividend date is Wednesday, September 11th. This is a positive change from Medical Properties Trust’s previous quarterly dividend of $0.25.
Medical Properties Trust has raised its dividend payment by an average of 4.4% annually over the last three years and has raised its dividend annually for the last 5 consecutive years. Medical Properties Trust has a dividend payout ratio of 74.8% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Medical Properties Trust to earn $1.57 per share next year, which means the company should continue to be able to cover its $1.04 annual dividend with an expected future payout ratio of 66.2%.
Medical Properties Trust stock opened at $18.97 on Tuesday. The stock has a fifty day moving average price of $18.20 and a 200 day moving average price of $18.14. Medical Properties Trust has a 52 week low of $13.98 and a 52 week high of $19.26. The firm has a market capitalization of $8.48 billion, a P/E ratio of 13.86, a PEG ratio of 3.70 and a beta of 0.56. The company has a current ratio of 8.00, a quick ratio of 8.00 and a debt-to-equity ratio of 0.99.
In related news, insider Emmett E. Mclean sold 100,000 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $18.37, for a total value of $1,837,000.00. Following the completion of the sale, the insider now directly owns 1,066,337 shares in the company, valued at approximately $19,588,610.69. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director G Steven Dawson acquired 7,476 shares of the business’s stock in a transaction on Thursday, August 8th. The stock was bought at an average cost of $18.07 per share, for a total transaction of $135,091.32. Following the completion of the transaction, the director now directly owns 76,302 shares of the company’s stock, valued at $1,378,777.14. The disclosure for this purchase can be found here. Insiders own 1.18% of the company’s stock.
MPW has been the subject of a number of recent analyst reports. SunTrust Banks boosted their target price on shares of Medical Properties Trust from $20.00 to $21.00 and gave the company a “buy” rating in a report on Tuesday, August 27th. Zacks Investment Research downgraded Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Wednesday, July 17th. JPMorgan Chase & Co. set a $21.00 target price on Medical Properties Trust and gave the stock a “buy” rating in a research report on Wednesday, September 4th. ValuEngine lowered Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Deutsche Bank upgraded Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Monday, July 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $19.35.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Further Reading: Strike Price
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.